medicines


  • 6-Jun-2006 Hankyoreh
    Ministry fears effects of FTA on healthcare system

    South Korean consumers will pay more for pharmaceuticals if US demands on a free trade agreement between the two countries are met, according to the Ministry of Health and Welfare.

  • 1-Jun-2006 TWN
    South American Ministers vow to avoid TRIPS-plus measures

    The Ministers of Health of ten South American countries issued a joint declaration on intellectual property committing themselves to avoid "TRIPS plus" provisions in bilateral and regional trade agreements, to facilitate the use of compulsory licensing and parallel importing and to avoid broadening the scope of patentability and the extension of patentable areas.

  • 15-May-2006 SERVINDI
    Perú: ¡Escándalo! Negociador del TLC pasa a laborar en multinacional de EEUU

    Una desagradable sorpresa se llevó el equipo peruano al enterarse que uno de los negociadores y defensores en la mesa de propiedad intelectual, de la noche a la mañana pasó a pertenecer a las filas de representantes de la empresa farmacéutica norteamericana Pfizer

  • 15-May-2006
    Bad blood over FTA

    Australia’s monopoly blood processor, CSL, has backed Red Cross calls for a ban on plasma imports and warned against opening up the nation’s supply network to overseas companies.

  • 15-May-2006
    Honest approach required in Korea-U.S. FTA negotiation

    I read an article by Woo Seok-gyun, an official from the Korea Federation of Medical Groups for Health Rights (KFHR), regarding the Korea-U.S. Free Trade Agreement (FTA) negotiation on medical care and education. Mr. Woo described the upcoming negotiation as a ’game of truth’ by the government.

  • 8-May-2006 ABC
    US drug company appeals PBS decision

    It’s just over a year since the Australia US Free Trade Agreement came into force, opening the door for US drug companies to force a review of decisions about which drugs are subsidised by the Australian Government. Now that power is being used by the US drug company Eli Lilly.

  • 26-Apr-2006 Oxfam
    A US Free Trade Agreement could threaten access to medicine in Thailand

    New stringent drug patent and marketing rules being negotiated in a Free Trade Agreement (FTA) between the US and Thailand would limit competition and reduce access to affordable medicines in Thailand.

  • 24-Apr-2006
    US-FTA blocks medicine for many

    The Guatemalan pharmaceutical industry is the strongest company in Central America and among the first 10 in Latin America, but it is today threatened by the free trade agreement (FTA) with United States.

  • 21-Apr-2006 3D
    Trade-related intellectual property rights, access to medicines and human rights - Morocco

    The briefing calls for an independent human rights impact assessment of the effect of intellectual property rules in the US-Morocco Free Trade Agreement (FTA) on access to medicines and the enjoyment of human rights in Morocco.

  • 20-Apr-2006 Oxfam America
    US-Peru free trade deal a step back for development

    International aid organization Oxfam criticized today’s signing of the US-Peru Free Trade Agreement (FTA) in Washington, an agreement it says would do more harm than good for millions of Peruvians who live in poverty.

  • 18-Apr-2006
    US pushes to limit generic drug rights

    Under global trading rules, the inventors of medicines ordinarily enjoy the right to a 20-year monopoly on their inventions. But five years ago, the United States joined 141 other countries to sign the Doha Declaration, confirming the right of poor countries to break drug patents and produce cheap generic drugs in the event of contagions like HIV.

  • 12-Apr-2006
    US biotech deal blazes Aussie trail

    At just $4million, it’s hardly the biggest biotech deal ever struck by an Australian company, but it’s an important first.

  • 10-Apr-2006 El Universo
    Venezuela desconoce decisión de socios andinos sobre patentes

    Venezuela “desconoce la decisión” de Perú, Colombia y Ecuador de no acatar la normativa andina sobre medicamentos genéricos y reiteró ayer que la unidad de la Comunidad Andina de Naciones (CAN) está bajo “amenaza”

  • 8-Apr-2006 EFE
    Colombia, Ecuador y Perú no acatarán norma andina sobre genéricos

    Colombia, Ecuador y Perú anunciaron hoy que no acatarán el capítulo de los medicamentos genéricos de las normas de la Comunidad Andina para seguir adelante hacia la suscripción de un Tratado de Libre Comercio con Estados Unidos.

  • 29-Mar-2006 Bolpress
    Soya boliviana, mercado colombiano, transgénicos y TLC

    Una semana antes de la firma del TLC con Estados Unidos, el gobierno colombiano ejerció una presión intensa sobre la Cancillería boliviana con el objetivo de lograr el apoyo a su propuesta de modificar una norma de la CAN (Comunidad Andina de Naciones), la Decisión 486 de Propiedad Intelectual

  • 27-Mar-2006 ANSA
    Laboratorios farmacéuticos latinoamericanos contra TLC con EE.UU.

    Laboratorios nacionales de quince países latinoamericanos pidieron a los gobiernos de la región que rechacen los tratados de libre comercio (TLC) con Estados Unidos que introduzcan cláusulas monopólicas en el mercado farmacéutico, en perjuicio del acceso a los medicamentos por parte de la población.

  • 26-Mar-2006 USTR
    The US-Peru Trade Promotion Agreement (TPA): The intellectual property provisions

    Report of the US government’s Industry Trade Advisory Committee on Intellectual Property Rights (ITAC-15)

  • 26-Mar-2006 El Comercio
    TLC: cinco mesas se han cerrado en la ronda final

    Luego de dos días de negociaciones en Washington, el equipo negociador del Tratado de Libre Comercio (TLC) de Ecuador ha logrado cerrar cuatro mesas, las cuales se suman a las siete que habían concluido en las rondas anteriores.

  • 24-Mar-2006
    FTA Watch statement: In support of Korean people’s struggle against the Korea-US FTA

    Although Thailand and South Korea are different in terms of development, people in both countries share a common demand for the protection of their right to affordable medicines and treatment.

  • 10-Mar-2006 El País
    Colombia: TLC y medicamentos

    Estudios de la OPS y la Universidad Nacional permiten afirmar que las concesiones hechas a EE.UU. ocasionarán un aumento del gasto en salud de cientos de millones de dólares anuales, lo que dejaría sin acceso a medicamentos a miles de colombianos. En sida, por ejemplo, el TLC podría privar de ARV a cerca de 4.000 pacientes cada año, los cuales quedarían condenados a morir en un lapso promedio de cinco años

  • 0 | ... | 420 | 440 | 460 | 480 | 500 | 520 | 540 | 560 | 580 | ... | 700